3Mackness B, Mackness MI, Arrol S, et al. Effect of the molecular polymorphisms of human paraoxonase (PONI)on the rate of hydrolysis of paraoxon[ J ]. Br J Pharmacol, 1997,122(2) : 265-268.
4Playfer JR, Eze LC, Bullen MF, et al. Genetic polymorphism and interethnic variability of plasma paraoxonase activity[J]. J Med Genet,1976,13(5) :337-342.
5Adkins S, Gan KN, Mody M, et al. Molecular basis for the polymorphic forms of human serum paraoxonase arylesterase: glutamine or arginine at position 191 for the respective A or B allozymes[ J] .Am J Hum Genet,1993,52(3) : 598-608.
6Li WF, Costa LC, Furlong CE. Serum paraoxonase status : a major factor in determing resistance to organophosphates [ J ]. Toxicol Environ Health, 1993,40(2 - 3) :337-346.
7Yang D,Li T, He F. Electroneurophysiological studies in rats of acute dimethoate poisoning[ J ]. Toxicol Lett, 1999,107( 1-3) :249-254.
8Johnson MK. The delayed neurotic effect of some organophos-phours compounds:identification of the phosphorylation site as an esterase. Biochem J, 1969,114:711-717.
9Johnson MK. Impeoved assay of neurotoxic esterase of screening organophosphates for delayed neurotoxicity potential. Arch Toxicity, 1977,37 ; 113-115.
